Electrical and mechanical stimulation of cardiac cells and tissue constructs

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 135-155

  Stoppel, Whitney L ^a   Kaplan, David L ^a   Black, Lauren D ^a,b  

^a Tufts University   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3D cardiac tissues; Bioreactors; Cardiac tissue engineering; Electrical stimulation; Electromechanical stimulation; Mechanical stimulation

Indexed keywords

BIOCONVERSION; BIOREACTORS; CELL ENGINEERING; CELLS; CYTOLOGY; HEART; HISTOLOGY; STEM CELLS; TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; ELECTRICAL STIMULATIONS; ELECTROMECHANICAL STIMULATION; MECHANICAL STIMULATION;

TISSUE;

BIOMATERIAL;

BIOMECHANICS; BIOREACTOR; CELL DIFFERENTIATION; CELL JUNCTION; CELL MATURATION; COMPRESSION; CONGENITAL HEART MALFORMATION; DRUG SCREENING; ELECTRIC CONDUCTIVITY; ELECTROSTIMULATION; FORCE; HEART; HEART CELL CULTURE; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART PERFUSION; HEART STIMULATION; HEART VENTRICLE HYPERTROPHY; HUMAN; MECHANICAL STIMULATION; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RIGIDITY; SIGNAL TRANSDUCTION; STEM CELL; STRETCHING; TISSUE ENGINEERING; ANIMAL; BIOLOGICAL MODEL; CARDIAC MUSCLE CELL; CELL COMMUNICATION; CELL CULTURE; CYTOLOGY; HEART CONTRACTION; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOMECHANICAL PHENOMENA; BIOREACTORS; CELL COMMUNICATION; CELLS, CULTURED; ELECTRIC CONDUCTIVITY; ELECTRIC STIMULATION; HEART; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; TISSUE ENGINEERING;

EID: 84951744929     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.07.009     Document Type: Review

References (383)

1. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2014, 131:e29-322.
2. Boyle A. Current status of cardiac transplantation and mechanical circulatory support. Curr. Heart Fail. Rep. 2009, 6:28-33.
3. Itescu S., John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann. Thorac. Surg. 2003, 75:S58-S65.
4. Cannata A., Taglieri C., Russo C.F., Bruschi G., Martinelli L. Use of CoSeal in a patient with a left ventricular assist device. Ann. Thorac. Surg. 2009, 87:1956-1958.
5. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 119:E391-E479.
6. Frantz S., Bauersachs J., Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc. Res. 2009, 81:474-481.
7. Christman K.L., Vardanian A.J., Fang Q.Z., Sievers R.E., Fok H.H., Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 2004, 44:654-660.
8. Tsuchikane E., Taketani S., Shimogami M., Sawa Y., Katoh O. A novel catheter system for percutaneous intracoronary artery cardiomyoplasty. J. Invasive Cardiol. 2008, 20:357-360.
9. Quevedo H.C., Hatzistergos K.E., Oskouei B.N., Feigenbaum G.S., Rodriguez J.E., Valdes D., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14022-14027.
10. Lee W.Y., Wei H.J., Lin W.W., Yeh Y.C., Hwang S.M., Wang J.J., et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials 2011, 32:5558-5567.
11. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
12. Templin C., Zweigerdt R., Schwanke K., Olmer R., Ghadri J.R., Emmert M.Y., et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation 2012, 126:430-439.
13. Williams A.R., Hatzistergos K.E., Addicott B., McCall F., Carvalho D., Suncion V., et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013, 127:213-223.
14. Seif-Naraghi S.B., Singelyn J.M., Salvatore M.A., Osborn K.G., Wang J.J., Sampat U., et al. Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med. 2013, 5:10.
15. Cheng K., Malliaras K., Smith R.R., Shen D., Sun B., Blusztajn A., et al. Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Circ. Heart Fail. 2014, 2:49-61.
16. Gerbin K.A., Yang X., Murry C.E., Coulombe K.L. Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts. PLoS One 2015, 10:e0131446.
17. Le Huu A., Prakash S., Shum-Tim D. Cellular cardiomyoplasty: current state of the field. Regen. Med. 2012, 7:571-582.
18. Jakob P., Landmesser U. Current status of cell-based therapy for heart failure. Curr. Heart Fail. Rep. 2013, 10:165-176.
19. Coppen S.R., Fukushima S., Shintani Y., Takahashi K., Varela-Carver A., Salem H., et al. A factor underlying late-phase arrhythmogenicity after cell therapy to the heart - Global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation. Circulation 2008, 118:S138-S144.
20. Fujimoto K.L., Guan J., Oshima H., Sakai T., Wagner W.R. In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures. Ann. Thorac. Surg. 2007, 83:648-654.
21. Miyagi Y., Chiu L.L., Cimini M., Weisel R.D., Radisic M., Li R.K. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 2011, 32:1280-1290.
22. Rane A.A., Christman K.L. Biomaterials for the treatment of myocardial infarction: a 5-year update. J. Am. Coll. Cardiol. 2011, 58:2615-2629.
23. Gaetani R., Feyen D.A.M., Verhage V., Slaats R., Messina E., Christman K.L., et al. Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarction. Biomaterials 2015, 61:339-348.
24. Roura S., Soler-Botija C., Bagó J.R., Llucià-Valldeperas A., Férnandez M.A., Gálvez-Montón C., et al. Postinfarction functional recovery driven by a three-dimensional engineered fibrin patch composed of human umbilical cord blood-derived mesenchymal stem cells. Stem Cells Transl. Med. 2015, 4:956-966.
25. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 1999, 64:580-589.
26. Bursac N., Papadaki M., White J.A., Eisenberg S.R., Vunjak-Novakovic G., Freed L.E. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng. 2003, 9:1243-1253.
27. Black L.D., Meyers J.D., Weinbaum J.S., Shvelidze Y.A., Tranquillo R.T. Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng. A 2009, 15:3099-3108.
28. Feinberg A.W., Ripplinger C.M., van der Meer P., Sheehy S.P., Domian I., Chien K.R., et al. Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes. Stem Cell Rep. 2013, 1:387-396.
29. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 2011, 109:47-59.
30. Kensah G., Lara A.R., Dahlmann J., Zweigerdt R., Schwanke K., Hegermann J., et al. Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur. Heart J. 2013, 34:1134-1146.
31. Zhang D., Shadrin I.Y., Lam J., Xian H.-Q., Snodgrass H.R., Bursac N. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34:5813-5820.
32. Chinali M., Simone Gd., Roman M.J., Bella J.N., Liu J.E., Lee E.T., et al. Left atrial systolic force and cardiovascular outcome*: the Strong Heart Study. Am. J. Hypertens. 2005, 18:1570-1576.
33. Morgan K.Y., Black L.D. It's all in the timing. Modeling isovolumic contraction through development and disease with a dynamic dual electromechanical bioreactor system. Organogenesis 2014, 10:317-322.
34. Morgan K.Y., Black L.D. Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs. Tissue Eng. A 2014, 20:1654-1667.
35. Young J.L., Engler A.J. Hydrogels with time-dependent material properties enhance cardiomyocyte differentiation in vitro. Biomaterials 2011, 32:1002-1009.
36. Vunjak-Novakovic G., Bhatia S., Chen C., Hirschi K. HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease. Stem Cell Res. Ther. 2013, S8.
37. Gjorevski N., Nelson C.M. The mechanics of development: models and methods for tissue morphogenesis. Birth Defects Res. C Embryo Today 2010, 90:193-202.
38. Taber L.A. Mechanical aspects of cardiac development. Prog. Biophys. Mol. Biol. 1998, 69:237-255.
39. Granados-Riveron J.T., Brook J.D. The impact of mechanical forces in heart morphogenesis. Circ. Cardiovasc. Genet. 2012, 5:132-142.
40. Heisenberg C.-P., Bellaïche Y. Forces in Tissue Morphogenesis and Patterning. Cell 2013, 153:948-962.
41. Wessels A.S.D. Developmental anatomy of the heart: a tale of mice and man. Physiol. Genomics 2003, 15:165-176.
42. Jacot J.G., Martin J.C., Hunt D.L. Mechanobiology of cardiomyocyte development. J. Biomech. 2010, 43:93-98.
43. Williams C., Quinn K.P., Georgakoudi I., Black L.D. Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro. Acta Biomater. 2014, 10:194-204.
44. Williams C., Black L. The role of extracellular matrix in cardiac development. Biomaterials for Cardiac Regeneration 2015, 1-35. Springer International Publishing. E.J. Suuronen, M. Ruel (Eds.).
45. Ibrahim M., Kukadia P., Siedlecka U., Cartledge J.E., Navaratnarajah M., Tokar S., et al. Cardiomyocyte Ca2+ handling and structure is regulated by degree and duration of mechanical load variation. J. Cell. Mol. Med. 2012, 16:2910-2918.
46. Kim M.S., Kewalramani G., Puthanveetil P., Lee V., Kumar U., An D., et al. Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization. Diabetes 2008, 57:64-76.
47. Streicher J.M., Ren S., Herschman H., Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 2010, 106:1434-1443.
48. Zhang W., Elimban V., Nijjar M.S., Gupta S.K., Dhalla N.S. Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp. Clin. Cardiol. 2003, 8:173-183.
49. Lal H., Verma S.K., Golden H.B., Foster D.M., Smith M., Dostal D.E. Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinases. J. Mol. Cell. Cardiol. 2008, 45:770-778.
50. Catalucci D., Condorelli G. Effects of Akt on cardiac myocytes: location counts. Circ. Res. 2006, 99:339-341.
51. Walsh K. Akt signaling and growth of the heart. Circulation 2006, 113:2032-2034.
52. Shiojima I., Yefremashvili M., Luo Z.Y., Kureishi Y., Takahashi A., Tao J.Z., et al. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem. 2002, 277:37670-37677.
53. Fujio Y., Nguyen T., Wencker D., Kitsis R.N., Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000, 101:660-667.
54. Zeidan A., Javadov S., Karmazyn M. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc. Res. 2006, 72:101-111.
55. Xin J., Guo B., Li Y. GW25-e4266 action and mechanism of secreted frizzled-related protein 5 in cardiomyocyte hypertrophy. J. Am. Coll. Cardiol. 2014, 64.
56. Yanazume T., Hasegawa K., Wada H., Morimoto T., Abe M., Kawamura T., et al. Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J. Biol. Chem. 2002, 277:8618-8625.
57. Palanivel R., Ganguly R., Turdi S., Xu A., Sweeney G. Adiponectin stimulates Rho-mediated actin cytoskeleton remodeling and glucose uptake via APPL1 in primary cardiomyocytes. Metab. Clin. Exp. 2014, 63:1363-1373.
58. Ganguly R., Schram K., Fang X., Kim M., Rodrigues B., Thong F.S.L., et al. Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes. Endocrinology 2011, 152:247-254.
59. Del Re D.P., Miyamoto S., Brown J.H. Focal adhesion kinase as a RhoA-activable signaling scaffold mediating akt activation and cardiomyocyte protection. J. Biol. Chem. 2008, 283:35622-35629.
60. Steinbusch L.K.M., Wijnen W., Schwenk R.W., Coumans W.A., Hoebers N.T.H., Ouwens D.M., et al. Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments. Am. J. Physiol. Cell Physiol. 2010, 298:C1549-C1559.
61. Dransfeld O., Rakatzi I., Sasson S., Gruzman A., Schmitt M., Haussinger D., et al. Eicosanoids participate in the regulation of cardiac glucose transport by contribution to a rearrangement of actin cytoskeletal elements. Biochem. J. 2001, 359:47-54.
62. Soliman H., Gador A., Lu Y.-H., Lin G., Bankar G., MacLeod K.M. Diabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKCβ2. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H989-H1000.
63. Zhang S.J., Truskey G.A., Kraus W.E. Effect of cyclic stretch on beta(1D)-integrin expression and activation of FAK and RhoA. Am. J. Physiol. Cell Physiol. 2007, 292:C2057-C2069.
64. Torsoni A.S., Marin T.M., Velloso L.A., Franchini K.G. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1488-H1496.
65. Adnane J., Bizouarn F.A., Qian Y.M., Hamilton A.D., Sebti S.M. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: Involvement of the small GTPase RhoA. Mol. Cell. Biol. 1998, 18:6962-6970.
66. Auer K.L., Park J.S., Seth P., Coffey R.J., Darlington G., Abo A., et al. Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21(Cip-1/WAF1)-null mice, but not in hepatocytes from p16(INK4a)-null mice. Biochem. J. 1998, 336:551-560.
67. Mammoto A., Huang S., Moore K., Oh P., Ingber D.E. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27(kip1) pathway and the G(1)/S transition. J. Biol. Chem. 2004, 279:26323-26330.
68. Del Re D.P., Miyamoto S., Brown J.H. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J. Biol. Chem. 2007, 282:8069-8078.
69. Chen C.S., Mrksich M., Huang S., Whitesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
70. Iskratsch T., Wolfenson H., Sheetz M.P. Appreciating force and shape - the rise of mechanotransduction in cell biology. Nat. Rev. Mol. Cell Biol. 2014, 15:825-833.
71. Haudek S.B., Gupta D., Dewald O., Schwartz R.J., Wei L., Trial J., et al. Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc. Res. 2009, 83:511-518.
72. Zhao L., Yang G., Zhao X. Rho-associated protein kinases play an important role in the differentiation of Rat adipose-derived stromal cells into cardiomyocytes in vitro. PLoS One 2014, 9:e115191.
73. Teramura T., Takehara T., Onodera Y., Nakagawa K., Hamanishi C., Fukuda K. Mechanical stimulation of cyclic tensile strain induces reduction of pluripotent related gene expressions via activation of Rho/ROCK and subsequent decreasing of AKT phosphorylation in human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 2012, 417:836-841.
74. Loirand G., Guérin P., Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 2006, 98:322-334.
75. Surma M., Wei L., Shi J. Rho kinase as a therapeutic target in cardiovascular disease. Futur. Cardiol. 2011, 7:657-671.
76. Pedersen E., Brakebusch C. Rho GTPase function in development: how in vivo models change our view. Exp. Cell Res. 2012, 318:1779-1787.
77. Schram K., Ganguly R., No E.K., Fang X., Thong F.S.L., Sweeney G. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 2011, 152:2037-2047.
78. Yang R., Chang L., Liu S., Jin X., Li Y. High glucose induces Rho/ROCK-dependent visfatin and type I procollagen expression in rat primary cardiac fibroblasts. Mol. Med. Rep. 2014, 10:1992-1998.
79. Manickam N., Patel M., Griendling K.K., Gorin Y., Barnes J.L. RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am. J. Physiol. Ren. Physiol. 2014, 307:F159-F171.
80. Thodeti C.K., Paruchuri S., Meszaros J.G. A TRP to cardiac fibroblast differentiation. Channels 2013, 7:211-214.
81. Wang Y.-S., Li S.-H., Guo J., Weisel R.D., Li R.-K. miR-145 is a key regulator of cardiac myofibroblast differentiation. Circulation 2012, 126:A11375.
82. Zhou Y., Huang X., Hecker L., Kurundkar D., Kurundkar A., Liu H., et al. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J. Clin. Invest. 2013, 123:1096-1108.
83. Takuwa N., Okamoto Y., Yoshioka K., Takuwa Y. Sphingosine-1-phosphate signaling and cardiac fibrosis. Inflamm. Regen. 2013, 33:96-108.
84. Ruwhof C., van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 2000, 47:23-37.
85. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad and the ugly. Annu. Rev. Physiol. 2003, 65:45-79.
86. Heineke J., Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 2006, 7:589-600.
87. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 2002, 91:776-781.
88. Ueyama T., Kawashima S., Sakoda T., Rikitake Y., Ishida T., Kawai M., et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J. Mol. Cell. Cardiol. 2000, 32:947-960.
89. Zou Y., Yao A., Zhu W., Kudoh S., Hiroi Y., Shimoyama M., et al. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 2001, 104:102-108.
90. Kehat I., Davis J., Tiburcy M., Accornero F., Saba-El-Leil M.K., Maillet M., et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ. Res. 2011, 108:176-183.
91. Li L., Cai H., Liu H., Guo T. β-adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy. Mol. Med. Rep. 2015, 11:4373-4380.
92. Kramann N., Hasenfuß G., Seidler T. B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy. Cardiovasc. Res. 2014, 102:88-96.
93. Yu L., Li M., She T., Shi C., Meng W., Wang B., et al. Endothelin-1 stimulates the expression of l-type Ca2+ channels in neonatal rat cardiomyocytes via the extracellular signal-regulated kinase 1/2 pathway. J. Membr. Biol. 2013, 246:343-353.
94. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Investig. 1997, 100:1813.
95. Zhao L., Peng D.-Q., Zhang J., Song J.-Q., Teng X., Yu Y.-R., et al. Extracellular signal-regulated kinase 1/2 activation is involved in intermedin1-53 attenuating myocardial oxidative stress injury induced by ischemia/reperfusion. Peptides 2012, 33:329-335.
96. Umoh N.A., Walker R.K., Millis R.M., Al-Rubaiee M., Gangula P.R., Haddad G.E. Calcitonin gene-related peptide regulates cardiomyocyte survival through regulation of oxidative stress by PI3K/Akt and MAPK signaling pathways. Ann. Clin. Exp. Hypertens. 2014, 2:1007.
97. Sun B., Sun G.B., Xiao J., Chen R.C., Wang X., Wu Y., et al. Isorhamnetin inhibits H2O2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J. Cell. Biochem. 2012, 113:473-485.
98. Cui C., Shi Q., Zhang X., Liu X., Bai Y., Li J., et al. CRP promotes MMP-10 expression via c-Raf/MEK/ERK and JAK1/ERK pathways in cardiomyocytes. Cell. Signal. 2012, 24:810-818.
99. Uosaki H., Magadum A., Seo K., Fukushima H., Takeuchi A., Nakagawa Y., et al. Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells. Circ. Cardiovasc. Genet. 2013, 6:624-633.
100. Yue T.-L., Wang C., Gu J.-L., Ma X.-L., Kumar S., Lee J.C., et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 2000, 86:692-699.
101. Liu Q., Hofmann P.A. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H2204-H2212.
102. Chen M., Sato P.Y., Chuprun J.K., Peroutka R.J., Otis N.J., Ibetti J., et al. Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting. Circ. Res. 2013, 112:1121-1134.
103. Zheng J., Koh X., Hua F., Li G., Larrick J.W., Bian J.-S. Cardioprotection induced by Na+/K+-ATPase activation involves extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt pathway. Cardiovasc. Res. 2011, 89:51-59.
104. Wang L., Li X., Zhou Y., Shi H., Xu C., He H., et al. Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis. Naunyn Schmiedeberg's Arch. Pharmacol. 2014, 387:197-206.
105. Chattergoon N.N., Louey S., Stork P.J., Giraud G.D., Thornburg K.L. Unexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2014, 307:H1216-H1225.
106. Liang Q., Wiese R.J., Bueno O.F., Dai Y.-S., Markham B.E., Molkentin J.D. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1-and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol. Cell. Biol. 2001, 21:7460-7469.
107. Raskin A., Lange S., Banares K., Lyon R.C., Zieseniss A., Lee L.K., et al. A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J. Biol. Chem. 2012, 287:29273-29284.
108. Lal H., Ahmad F., Woodgett J., Force T. The GSK-3 Family as Therapeutic Target for Myocardial Diseases. Circ. Res. 2015, 116:138-149.
109. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., et al. ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 2001, 89:661-669.
110. Chen K.D., Li Y.S., Kim M., Li S., Yuan S., Chien S., et al. Mechanotransduction in response to shear stress. J. Biol. Chem. 1999, 274:18393-18400.
111. Arthur W.T., Petch L.A., Burridge K. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Current Biology 2000, 10:719-722.
112. Burridge K., Turner C.E., Romer L.H. Tyrosine phosphorylation of paxillin and Pp125(Fak) accompanies cell-adhesion to extracellular-matrix - a role in cytoskeletal assembly. J. Cell Biol. 1992, 119:893-903.
113. Bottazzi M.E., Zhu X.Y., Bohmer R.M., Assoian R.K. Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol. 1999, 146:1255-1264.
114. Assoian R.K. Anchorage-dependent cell cycle progression. J. Cell Biol. 1997, 136:1-4.
115. Schwartz M.A., Assoian R.K. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 2001, 114:2553-2560.
116. Schwartz M.A., DeSimone D.W. Cell adhesion receptors in mechanotransduction. Curr. Opin. Cell Biol. 2008, 20:551-556.
117. Zutter M.M. Integrin-mediated adhesion: tipping the balance between chemosensitivity and chemoresistance. Breast Cancer Chemosensitivity 2007, 608:87-100.
118. Manning A., McLachlan J.C. Looping of chick-embryo hearts invitro. J. Anat. 1990, 168:257-263.
119. Maenner J. The anatomy of cardiac looping: a step towards the understanding of the morphogenesis of several forms of congenital cardiac malformations. Clin. Anat. 2009, 22:21-35.
120. Latacha K.S., Remond M.C., Ramasubramanian A., Chen A.Y., Elson E.L., Taber L.A. Role of actin polymerization in bending of the early heart tube. Dev. Dyn. 2005, 233:1272-1286.
121. Noël E.S., Verhoeven M., Lagendijk A.K., Tessadori F., Smith K., Choorapoikayil S., et al. A nodal-independent and tissue-intrinsic mechanism controls heart-looping chirality. Nat. Commun. 2013, 4.
122. Manasek F.J., Burnside M.B., Waterman R.E. Myocardial cell shape change as a mechanism of embryonic heart looping. Dev. Biol. 1972, 29:349-371.
123. Auman H.J., Coleman H., Riley H.E., Olale F., Tsai H.-J., Yelon D. Functional modulation of cardiac form through regionally confined cell shape changes. PLoS Biol. 2007, 5:604-615.
124. Topper J.N., Gimbrone M.A. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol. Med. Today 1999, 5:40-46.
125. Vogel M., McElhinney D.B., Marcus E., Morash D., Jennings R.W., Tworetzky W. Significance and outcome of left heart hypoplasia in fetal congenital diaphragmatic hernia. Ultrasound Obstet. Gynecol. J. Int. Soc. Ultrasound Obstet. Gynecol. 2010, 35:310-317.
126. Nishimura M., Taniguchi A., Imanaka H., Taenaka N. Hypoplastic left heart syndrome associated with congenital right-sided diaphragmatic hernia and omphalocele. Chest 1992, 101:263-264.
127. Banerjee I., Carrion K., Serrano R., Dyo J., Sasik R., Lund S., et al. Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling. J. Mol. Cell. Cardiol. 2015, 79:133-144.
128. Terada R., Warren S., Lu J.T., Chien K.R., Wessels A., Kasahara H. Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc. Res. 2011, 91:289-299.
129. Schott J.-J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
130. Kirby M.L., Sahn D.J. Mouse models of congenital heart defects: what's missing?. Circ. Cardiovasc. Imaging 2010, 3:228-230.
131. Sedmera D., Hu N., Weiss K.M., Keller B.B., Denslow S., Thompson R.P. Cellular changes in experimental left heart hypoplasia. Anat. Rec. 2002, 267:137-145.
132. Migliazza L., Otten C., Xia H., Rodriguez J.I., Diez-Pardo J.A., Tovar J.A. Cardiovascular malformations in congenital diaphragmatic hernia: human and experimental studies. J. Pediatr. Surg. 1999, 34:1352-1358.
133. Guarino N., Shima H., Puri P. The hypoplastic heart in congenital diaphragmatic hernia: reduced expression of basic fibroblast growth factor and platelet-derived growth factor. Pediatr. Surg. Int. 2000, 16:243-246.
134. Takayasu H., Sato H., Sugimoto K., Puri P. Downregulation of GATA4 and GATA6 in the heart of rats with nitrofen-induced diaphragmatic hernia. J. Pediatr. Surg. 2008, 43:362-366.
135. Guan J., Wang F., Li Z., Chen J., Guo X., Liao J., et al. The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics. Biomaterials 2011, 32:5568-5580.
136. Maitra M., Schluterman M.K., Nichols H.A., Richardson J.A., Lo C.W., Srivastava D., et al. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev. Biol. 2009, 326:368-377.
137. Guarino N., Shima H., Puri P. Structural immaturity of the heart in congenital diaphragmatic hernia in rats. J. Pediatr. Surg. 2001, 36:770-773.
138. Bernardo B.C., Weeks K.L., Pretorius L., McMullen J.R. Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies. Pharmacol. Ther. 2010, 128:191-227.
139. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. Faseb. J. 2000, 14:669-679.
140. Leychenko A., Konorev E., Jijiwa M., Matter M.L. Stretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes. PLoS One 2011, 6:e29055.
141. Shyy J.Y.J., Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr. Opin. Cell Biol. 1997, 9:707-713.
142. Pluim B.M., Zwinderman A.H., van der Laarse A., van der Wall E.E. The athlete's heart - a meta-analysis of cardiac structure and function. Circulation 2000, 101:336-344.
143. Grossman W., Jones D., McLaurin L.P. Wall stress and patterns of hypertrophy in human left-ventricle. J. Clin. Investig. 1975, 56:56-64.
144. Choukroun G., Hajjar R., Fry S., del Monte F., Haq S., Guerrero J.L., et al. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH2-terminal kinases. J. Clin. Investig. 1999, 104:391-398.
145. Choukroun G., Hajjar R., Kyriakis J.M., Bonventre J.V., Rosenzweig A., Force T. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J. Clin. Investig. 1998, 102:1311-1320.
146. Komuro I., Kudo S., Yamazaki T., Zou Y.Z., Shiojima I., Yazaki Y. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. Faseb. J. 1996, 10:631-636.
147. Wang Y.B., Huang S.A., Sah V.P., Ross J., Brown J.H., Han J.H., et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 1998, 273:2161-2168.
148. Wang Y.B., Su B., Sah V.P., Brown J.H., Han J.H., Chien K.R. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 1998, 273:5423-5426.
149. Sadoshima J., Jahn L., Takahashi T., Kulik T.J., Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. an in vitro model of load-induced cardiac hypertrophy. J. Biol. Chem. 1992, 267:10551-10560.
150. Eghbali M., Deva R., Alioua A., Minosyan T.Y., Ruan H.M., Wang Y.B., et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ. Res. 2005, 96:1208-1216.
151. Eghbali M., Wang Y.B., Toro L., Stefani E. Heart hypertrophy during pregnancy: a better functioning heart?. Trends Cardiovasc. Med. 2006, 16:285-291.
152. McMullen J.R., Shioi T., Zhang L., Tarnavski O., Sherwood M.C., Kang P.M., et al. Phosphoinositide 3-kinase(p110 alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12355-12360.
153. Luo J., McMullen J.R., Sobkiw C.L., Zhang L., Dorfman A.L., Sherwood M.C., et al. Class I-A phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 2005, 25:9491-9502.
154. Pretorius L., Owen K.L., Jennings G.L., McMullen J.R. Promoting physiological hypertrophy in the failing heart. Clin. Exp. Pharmacol. Physiol. 2008, 35:438-441.
155. Iemitsu M., Miyauchi T., Maeda S., Sakai S., Kobayashi T., Fujii N., et al. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 281:R2029-R2036.
156. Serneri G.G.N., Boddi M., Modesti P.A., Cecioni I., Coppo M., Padeletti L., et al. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 2001, 89:977-982.
157. Oka T., Xu J., Molkentin J.D. Re-employment of developmental transcription factors in adult heart disease. Semin. Cell Dev. Biol. 2007, 18:117-131.
158. McMullen J.R., Jennings G.L. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin. Exp. Pharmacol. Physiol. 2007, 34:255-262.
159. Berenji K., Drazner M.H., Rothermel B.A., Hill J.A. Does load-induced ventricular hypertrophy progress to systolic heart failure?. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H8-H16.
160. Weinberg E.O., Thienelt C.D., Katz S.E., Bartunek J., Tajima M., Rohrbach S., et al. Gender differences in molecular remodeling in pressure overload hypertrophy. J. Am. Coll. Cardiol. 1999, 34:264-273.
161. Konhilas J.P., Maass A.H., Luckey S.W., Stauffer B.L., Olson E.N., Leinwand L.A. Sex modifies exercise and cardiac adaptation in mice. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2768-H2776.
162. Schaible T.F., Scheuer J. Effects of physical training by running or swimming on ventricular performance of rat hearts. J. Appl. Physiol. 1979, 46:854-860.
163. Schaible T.F., Scheuer J. Cardiac-function in hypertrophied hearts from chronically exercised female rats. J. Appl. Physiol. 1981, 50:1140-1145.
164. Skavdahl M., Steenbergen C., Clark J., Myers P., Demianenko T., Mao L., et al. Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H469-H476.
165. Van Aelst L.N., Voss S., Carai P., Van Leeuwen R., Vanhoutte D., Sanders-van Wijk S., et al. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening. Circ. Res. 2015, 116:425-436.
166. Mesirca P., Torrente A.G., Mangoni M.E. Functional role of voltage gated Ca(2+) channels in heart automaticity. Front. Physiol. 2015, 6:19.
167. Fahrenbach J.P., Mejia-Alvarez R., Banach K. The relevance of non-excitable cells for cardiac pacemaker function. J. Physiol. 2007, 585:565-578.
168. Dorn T., Goedel A., Lam J.T., Haas J., Tian Q., Herrmann F., et al. Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity. Stem Cells 2015, 33:1113-1129.
169. Mangoni M.E., Couette B., Bourinet E., Platzer J., Reimer D., Striessnig J., et al. Functional role of L-type Cav1. 3 Ca2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. 2003, 100:5543-5548.
170. DiFrancesco D., Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991, 351:145-147.
171. Bikkina M., Larson M.G., Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J. Am. Coll. Cardiol. 1993, 22:1111-1116.
172. Curran M.E., Splawski I., Timothy K.W., Vincen G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
173. Khan R., Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta(1) in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006, 118:10-24.
174. Xiao Y., Zhang B.Y., Liu H.J., Miklas J.W., Gagliardi M., Pahnke A., et al. Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle. Lab Chip 2014, 14:869-882.
175. Zhao Y., Feric N.T., Thavandiran N., Nunes S.S., Radisic M. The Role of Tissue Engineering and Biomaterials in Cardiac Regenerative Medicine. Can. J. Cardiol. 2014, 30:1307-1322.
176. Nunes S.S., Miklas J.W., Liu J., Aschar-Sobbi R., Xiao Y., Zhang B., et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10:781-787.
177. Thavandiran N., Dubois N., Mikryukov A., Massé S., Beca B., Simmons C.A., et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. 2013, 110:E4698-E4707.
178. Hauser M., Eicken A., Kuehn A., Hess J., Fratz S., Ewert P., et al. Managing the right ventricular outflow tract for pulmonary regurgitation after tetralogy of Fallot repair. Heart Asia 2013, 5:106-111.
179. Chi N.C., Shaw R.M., Jungblut B., Huisken J., Ferrer T., Arnaout R., et al. Genetic and physiologic dissection of the vertebrate cardiac conduction system. PLoS Biol. 2008, 6:1006-1019.
180. Chi N.C., Bussen M., Brand-Arzamendi K., Ding C., Olgin J.E., Shaw R.M., et al. Cardiac conduction is required to preserve cardiac chamber morphology. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14662-14667.
181. Sedmera D., Reckova M., deAlmeida A., Sedmerova M., Biermann M., Volejnik J., et al. Functional and morphological evidence for a ventricular conduction system in zebrafish and Xenopus hearts. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1152-H1160.
182. Tu S., Chi N.C. Zebrafish models in cardiac development and congenital heart birth defects. Differentiation 2012, 84.
183. Arrenberg A.B., Stainier D.Y.R., Baier H., Huisken J. Optogenetic Control of Cardiac Function. Science 2010, 330:971-974.
184. Ye K.Y., Black L.D. Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J. Cardiovasc. Transl. Res. 2011, 4:575-591.
185. Seki A, Nishii K, Hagiwara N. Gap junctional regulation of pressure, fluid force, and electrical fields in the epigenetics of cardiac morphogenesis and remodeling. Life Sciences.
186. Kumai M., Nishii K., Nakamura K., Takeda N., Suzuki M., Shibata Y. Loss of connexin45 causes a cushion defect in early cardiogenesis. Development 2000, 127:3501-3512.
187. Saez J.C., Berthoud V.M., Branes M.C., Martinez A.D., Beyer E.C. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 2003, 83:1359-1400.
188. Gros D., Théveniau-Ruissy M., Bernard M., Calmels T., Kober F., Söhl G., et al. Connexin 30 is expressed in the mouse sino-atrial node, and modulates heart rate. Cardiovasc. Res. 2009, cvp280.
189. Kreuzberg M.M., Söhl G., Kim J.-S., Verselis V.K., Willecke K., Bukauskas F.F. Functional properties of mouse connexin30. 2 expressed in the conduction system of the heart. Circ. Res. 2005, 96:1169-1177.
190. Beauchamp P., Desplantez T., McCain M.L., Li W., Asimaki A., Rigoli G., et al. Electrical coupling and propagation in engineered ventricular myocardium with heterogeneous expression of connexin43. Circ. Res. 2012, 110:1445-1453.
191. Kirchhoff S., Nelles E., Hagendorff A., Krüger O., Traub O., Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr. Biol. 1998, 8:299-302.
192. Reaume A.G., de Sousa P.A., Kulkarni S., Langille B.L., Zhu D., Davies T.C., et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995, 267:1831-1834.
193. Simon A.M., Goodenough D.A., Paul D.L. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr. Biol. 1998, 8:295-298.
194. Gu H., Smith F.C., Taffet S.M., Delmar M. High incidence of cardiac malformations in connexin40-deficient mice. Circ. Res. 2003, 93:201-206.
195. Sankova B., Benes J., Krejci E., Dupays L., Theveniau-Ruissy M., Miquerol L., et al. The effect of connexin40 deficiency on ventricular conduction system function during development. Cardiovasc. Res. 2012, cvs210.
196. Britz-Cunningham S.H., Shah M.M., Zuppan C.W., Fletcher W.H. Mutations of the connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N. Engl. J. Med. 1995, 332:1323-1330.
197. Huang G.-Y., Xie L.-J., Linask K.L., Zhang C., Zhao X.-Q., Yang Y., et al. Evaluating the role of connexin43 in congenital heart disease: screening for mutations in patients with outflow tract anomalies and the analysis of knock-in mouse models. J. Cardiovasc. Dis. Res. 2011, 2:206-212.
198. Ruttenstock E.M., Doi T., Dingemann J., Puri P. Prenatal retinoic acid upregulates connexin 43 (Cx43) gene expression in pulmonary hypoplasia in the nitrofen-induced congenital diaphragmatic hernia rat model. J. Pediatr. Surg. 2012, 47:336-340.
199. Izumi K., Lippa A.M., Wilkens A., Feret H.A., McDonald-McGinn D.M., Zackai E.H. Congenital heart defects in oculodentodigital dysplasia: report of two cases. Am. J. Med. Genet. A 2013, 161:3150-3154.
200. Salameh A., Blanke K., Daehnert I. Role of connexins in human congenital heart disease: the chicken and egg problem. Front. Pharmacol. 2013, 4.
201. Salameh A., Wustmann A., Karl S., Blanke K., Apel D., Rojas-Gomez D., et al. Cyclic mechanical stretch induces cardiomyocyte orientation and polarization of the gap junction protein connexin43. Circ. Res. 2010, 106:1592-1602.
202. Lieu D.K., Fu J.-D., Chiamvimonvat N., Tung K.C., McNerney G.P., Huser T., et al. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Arrhythm. Electrophysiol. 2013, 6:191-201.
203. Bierhuizen M.F., Boulaksil M., van Stuijvenberg L., van der Nagel R., Jansen A.T., Mutsaers N.A., et al. In calcineurin-induced cardiac hypertrophy expression of Nav1.5, Cx40 and Cx43 is reduced by different mechanisms. J. Mol. Cell. Cardiol. 2008, 45:373-384.
204. Munoz-Esparza C., Garcia-Molina E., Salar-Alcaraz M., Penafiel-Verdu P., Sanchez-Munoz J.J., Martinez Sanchez J., et al. Heterogeneous phenotype of long QT syndrome caused by the KCNH2-H562R mutation: importance of familial genetic testing. Rev. Esp. Cardiol. (Engl Ed) 2015.
205. Anumonwo J.M. Pandit SV 2015, Ionic mechanisms of arrhythmogenesis, Trends Cardiovasc Med.
206. de Llano C.T., Campuzano O., Perez-Serra A., Mademont I., Coll M., Allegue C., et al. Further evidence of the association between LQT syndrome and epilepsy in a family with KCNQ1 pathogenic variant. Seizure 2015, 25:65-67.
207. Xiong Q., Cao Q., Zhou Q., Xie J., Shen Y., Wan R., et al. Arrhythmogenic cardiomyopathy in a patient with a rare loss-of-function KCNQ1 mutation. J. Am. Heart Assoc. 2015, 4:e001526.
208. Ye F., Yuan F., Li X., Cooper N., Tinney J.P., Keller B.B. Gene expression profiles in engineered cardiac tissues respond to mechanical loading and inhibition of tyrosine kinases. Physiol. Rep. 2013, 1:e00078.
209. Haggart C.R., Ames E.G., Lee J.K., Holmes J.W. Effects of stretch and shortening on gene expression in intact myocardium. Physiol. Genomics 2014, 46:57-65.
210. Tallawi M., Rai R., Boccaccini A.R., Aifantis K.E. Effect of substrate mechanics on cardiomyocyte maturation and growth. Tissue Eng. B Rev. 2014, 21:157-165.
211. Gershlak J.R., Resnikoff J.I., Sullivan K.E., Williams C., Wang R.M., Black L.D. Mesenchymal stem cells ability to generate traction stress in response to substrate stiffness is modulated by the changing extracellular matrix composition of the heart during development. Biochem. Biophys. Res. Commun. 2013, 439:161-166.
212. Bhana B., Iyer R.K., Chen W.L.K., Zhao R., Sider K.L., Likhitpanichkul M., et al. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol. Bioeng. 2010, 105:1148-1160.
213. Jacot J.G., McCulloch A.D., Omens J.H. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys. J. 2008, 95:3479-3487.
214. Engler A.J., Carag-Krieger C., Johnson C.P., Raab M., Tang H.Y., Speicher D.W., et al. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J. Cell Sci. 2008, 121:3794-3802.
215. Galie P.A., Khalid N., Carnahan K.E., Westfall M.V., Stegemann J.P. Substrate stiffness affects sarcomere and costamere structure and electrophysiological function of isolated adult cardiomyocytes. Cardiovasc. Pathol. 2013, 22:219-227.
216. Walker L.A., Medway A.M., Walker J.S., Cleveland J.C., Buttrick P.M. Tissue procurement strategies affect the protein biochemistry of human heart samples. J. Muscle Res. Cell Motil. 2011, 31:309-314.
217. Hidalgo C., Hudson B., Bogomolovas J., Zhu Y., Anderson B., Greaser M., et al. PKC phosphorylation of titin's PEVK Element. A novel and conserved pathway for modulating myocardial stiffness. Circ. Res. 2009, 105:631-638.
218. Krüger M., Kötter S., Grützner A., Lang P., Andresen C., Redfield M.M., et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ. Res. 2009, 104:87-94.
219. Rehfeldt F., Brown A.E.X., Raab M., Cai S., Zajac A.L., Zemel A., et al. Hyaluronic acid matrices show matrix stiffness in 2D and 3D dictates cytoskeletal order and myosin-II phosphorylation within stem cells. Integr. Biol. 2012, 4:422-430.
220. Vogel V. Mechanotransduction involving multimodular proteins: converting force into biochemical signals. Annu. Rev. Biophys. Biomol. Struct. 2006, 35:459-488.
221. Kang N., Shah V.H., Urrutia R. Membrane-to-nucleus signals and epigenetic mechanisms for myofibroblastic activation and desmoplastic stroma: potential therapeutic targets for liver metastasis?. Mol. Cancer Res. 2015, 13:604-612.
222. Hazeltine L.B., Simmons C.S., Salick M.R., Lian X., Badur M.G., Han W., et al. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int. J. Cell Biol. 2012, 2012.
223. Majkut S.F., Discher D.E. Cardiomyocytes from late embryos and neonates do optimal work and striate best on substrates with tissue-level elasticity: metrics and mathematics. Biomech. Model. Mechanobiol. 2012, 11:1219-1225.
224. Rodriguez Anthony G., Han Sangyoon J., Regnier M., Sniadecki Nathan J. Substrate stiffness increases twitch power of neonatal cardiomyocytes in correlation with changes in myofibril structure and intracellular calcium. Biophys. J. 2011, 101:2455-2464.
225. Wang P.-Y., Yu J., Lin J.-H., Tsai W.-B. Modulation of alignment, elongation and contraction of cardiomyocytes through a combination of nanotopography and rigidity of substrates. Acta Biomater. 2011, 7:3285-3293.
226. Bajaj P., Tang X., Saif T.A., Bashir R. Stiffness of the substrate influences the phenotype of embryonic chicken cardiac myocytes. J. Biomed. Mater. Res. A 2010, 95A:1261-1269.
227. Forte G., Pagliari S., Ebara M., Uto K., Tam J.K.V., Romanazzo S., et al. Substrate stiffness modulates gene expression and phenotype in neonatal cardiomyocytes in vitro. Tissue Eng. A 2012, 18:1837-1848.
228. Trappmann B., Gautrot J.E., Connelly J.T., Strange D.G.T., Li Y., Oyen M.L., et al. Extracellular-matrix tethering regulates stem-cell fate. Nat. Mater. 2012, 11:642-649.
229. Engler A.J., Griffin M.A., Sen S., Bonnetnann C.G., Sweeney H.L., Discher D.E. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J. Cell Biol. 2004, 166:877-887.
230. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126:677-689.
231. Ivashchenko C.Y., Pipes G.C., Lozinskaya I.M., Lin Z., Xiaoping X., Needle S., et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H913-H922.
232. Mummery C.L., Zhang J., Ng E.S., Elliott D.A., Elefanty A.G., Kamp T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ. Res. 2012, 111:344-358.
233. Veerman C.C., Kosmidis G., Mummery C.L., Casini S., Verkerk A.O., Bellin M. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?. Stem Cells Dev. 2015, 24:1035-1052.
234. Feric N.T., Radisic M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv. Drug Deliv. Rev. 2016, 96:110-134.
235. Vincent L.G., Engler A.J. Stem cell differentiation: post-degradation forces kick in. Nat. Mater. 2013, 12:384-386.
236. Tse J.R., Engler A.J. Stiffness gradients mimicking in vivo tissue variation regulate mesenchymal stem cell fate. PLoS One 2011, 6:e15978.
237. Salick M.R., Napiwocki B.N., Sha J., Knight G.T., Chindhy S.A., Kamp T.J., et al. Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes. Biomaterials 2014, 35:4454-4464.
238. Rao C., Prodromakis T., Kolker L., Chaudhry U.A.R., Trantidou T., Sridhar A., et al. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 2013, 34:2399-2411.
239. Tse J.R., Engler A.J. Preparation of hydrogel substrates with tunable mechanical properties. Current Protocols in Cell Biology 2001, John Wiley & Sons, Inc.
240. Gershlak J.R., Black L.D. Beta 1 integrin binding plays a role in the constant traction force generation in response to varying stiffness for cells grown on mature cardiac extracellular matrix. Exp. Cell Res. 2015, 330:311-324.
241. Simpson D.G., Sharp W.W., Borg T.K., Price R.L., Samarel A.M., Terracio L. Mechanical regulation of cardiac myofibrillar structure. Ann. N. Y. Acad. Sci. 1995, 752:131-140.
242. Simpson D.G., Sharp W.W., Borg T.K., Price R.L., Terracio L., Samarel A.M. Mechanical regulation of cardiac myocyte protein turnover and myofibrillar structure. Am. J. Physiol. Cell Physiol. 1996, 270:C1075-C1087.
243. Sigurdson W., Ruknudin A., Sachs F. Calcium imaging of mechanically induced fluxes in tissue-cultured chick heart: role of stretch-activated ion channels. Am. J. Physiol. Heart Circ. Physiol. 1992, 262:H1110-H1115.
244. Hu H., Sachs F. Stretch-activated ion channels in the heart. J. Mol. Cell. Cardiol. 1997, 29:1511-1523.
245. Sharp W.W., Simpson D.G., Borg T.K., Samarel A.M., Terracio L. Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 1997, 273:H546-H556.
246. van Wamel J.E., Ruwhof C., van der Valk-Kokshoorn E.J., Schrier P.I., van der Laarse A. Rapid gene transcription induced by stretch in cardiac myocytes and fibroblasts and their paracrine influence on stationary myocytes and fibroblasts. Pflugers Arch. 2000, 439:781-788.
247. Vandenburgh H.H., Solerssi R., Shansky J., Adams J.W., Henderson S.A. Mechanical stimulation of organogenic cardiomyocyte growth in vitro. Am. J. Physiol. Cell Physiol. 1996, 270:C1284-C1292.
248. Hoh J.F.Y., McGrath P.A., Hale P.T. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J. Mol. Cell. Cardiol. 1978, 10:1053-1076.
249. Nadal-Ginard B., Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J. Clin. Invest. 1989, 84:1693.
250. Dhein S., Schreiber A., Steinbach S., Apel D., Salameh A., Schlegel F., et al. Mechanical control of cell biology. Effects of cyclic mechanical stretch on cardiomyocyte cellular organization. Prog. Biophys. Mol. Biol. 2014, 115:93-102.
251. Aikawa R., Komuro I., Yamazaki T., Zou Y.Z., Kudoh S., Zhu W.D., et al. Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ. Res. 1999, 84:458-466.
252. Malhotra R., D'Souza K.M., Staron M.L., Birukov K.G., Bodi I., Akhter S.A. G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C. J. Biol. Chem. 2010, 285:13748-13760.
253. Crosara-Alberto D.P., Inoue R.Y., Costa C.R. FAK signalling mediates NF-kappaB activation by mechanical stress in cardiac myocytes. Clin Chim Acta 2009, 403:81-86.
254. Applications of Flexcell products Applying Mechanical Load to Cells in Monolayer 2015.
255. Banes A.J., Gilbert J., Taylor D., Monbureau O. A new vacuum-operated stress-providing instrument that applies static or variable duration cyclic tension or compression to cells in vitro. J. Cell Sci. 1985, 75:35-42.
256. Salameh A., Karl S., Djilali H., Dhein S., Janousek J., Daehnert I. Opposing and synergistic effects of cyclic mechanical stretch and alpha- or beta-adrenergic stimulation on the cardiac gap junction protein Cx43. Pharmacol. Res. 2010, 62:506-513.
257. Takahashi N., Seko Y., Noiri E., Tobe K., Kadowaki T., Sabe H., et al. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Circ. Res. 1999, 84:1194-1202.
258. Zentilin L., Puligadda U., Lionetti V., Zacchigna S., Collesi C., Pattarini L., et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. Faseb J. 2010, 24:1467-1478.
259. Ferrarini M., Arsic N., Recchia F.A., Zentilin L., Zacchigna S., Xu X., et al. Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ. Res. 2006, 98:954-961.
260. Shyu K.G., Wang B.W., Lin C.M., Chang H. Cyclic stretch enhances the expression of toll-like receptor 4 gene in cultured cardiomyocytes via p38 MAP kinase and NF-kappaB pathway. J. Biomed. Sci. 2010, 17:15.
261. Baker E.L., Zaman M.H. The biomechanical integrin. J. Biomech. 2010, 43:38-44.
262. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984.
263. Blaauw E., van Nieuwenhoven F.A., Willemsen P., Delhaas T., Prinzen F.W., Snoeckx L.H., et al. Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H780-H787.
264. Sadoshima J.-I., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ. Res. 1993, 73:413-423.
265. Nishimura Y., Inoue T., Morooka T., Node K. Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor alpha2 expression in rat neonatal cardiomyocytes. Circ. J. Off. J. Jpn. Circ Soc. 2008, 72:647-653.
266. Braz J.C., Bueno O.F., De Windt L.J., Molkentin J.D. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J. Cell Biol. 2002, 156:905-919.
267. Sabri A., Steinberg S.F. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol. Cell. Biochem. 2003, 251:97-101.
268. Dorn G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Investig. 2005, 115:527-537.
269. Ricci M., Mohapatra B., Urbiztondo A., Birusingh R.J., Morgado M., Rodriguez M.M., et al. Differential changes in TGF-beta/BMP signaling pathway in the right ventricular myocardium of newborns with hypoplastic left heart syndrome. J. Card. Fail. 2010, 16:628-634.
270. Abbott A. Cell culture: biology's new dimension. Nature 2003, 424:870-872.
271. Huebsch N., Arany P.R., Mao A.S., Shvartsman D., Ali O.A., Bencherif S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat. Mater. 2010, 9:518-526.
272. Chaudhuri O., Mooney D.J. Stem-cell differentiation: anchoring cell-fate cues. Nat. Mater. 2012, 11:568-569.
273. Griffin M.A., Engler A.J., Barber T.A., Healy K.E., Sweeney H.L., Discher D.E. Patterning, prestress, and peeling dynamics of myocytes. Biophys. J. 2004, 86:1209-1222.
274. Holle A.W., Engler A.J. More than a feeling: discovering, understanding, and influencing mechanosensing pathways. Curr. Opin. Biotechnol. 2011, 22:648-654.
275. Young J.L., Tuler J., Braden R., Shup-Magoffin P., Christman K.L., Engler A.J. Dynamic hyaluronic acid hydrogels for cardiac therapy are biocompatible and degradable. J. Tissue Eng. Regen. Med. 2012, 6:192-.
276. Rangarajan S., Madden L., Bursac N. Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles. Ann. Biomed. Eng. 2014, 42:1391-1405.
277. Massai D., Cerino G., Gallo D., Pennella F., Deriu M.A., Rodriguez A., et al. Bioreactors as engineering support to treat cardiac muscle and vascular disease. J. Health Care Eng. 2013, 4:329-370.
278. Chen Q.-Z., Harding S.E., Ali N.N., Lyon A.R., Boccaccini A.R. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater. Sci. Eng. R. Rep. 2008, 59:1-37.
279. Shapira-Schweitzer K., Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater. 2007, 3:33-41.
280. Stoppel W.L., Hu D., Domian I.J., Kaplan D.L., Black L.D. Anisotropic silk biomaterials containing cardiac extracellular matrix for cardiac tissue engineering. Biomed. Mater. 2015, 10:034105.
281. Kluge J., Leisk G., Cardwell R., Fernandes A., House M., Ward A., et al. Bioreactor system using noninvasive imaging and mechanical stretch for biomaterial screening. Ann. Biomed. Eng. 2011, 39:1390-1402.
282. Birla R.K., Huang Y.C., Dennis R.G. Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng. 2007, 13:2239-2248.
283. Cha J.M., Park T.N., Noh T.H., Suh T. Time-dependent modulation of alignment and differentiation of smooth muscle cells seeded on a porous substrate undergoing cyclic mechanical strain. Artif. Organs 2006, 30:250-258.
284. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000, 68:106-114.
285. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.
286. Galie P.A., Byfield F.J., Chen C.S., Kresh J.Y., Janmey P.A. Mechanically stimulated contraction of engineered cardiac constructs using a microcantilever. IEEE Trans. Bio-med. Eng. 2015, 62:438-442.
287. Legant W.R., Pathak A., Yang M.T., Deshpande V.S., McMeeking R.M., Chen C.S. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc. Natl. Acad. Sci. 2009, 106:10097-10102.
288. Galie P.A., Stegemann J.P. Simultaneous application of interstitial flow and cyclic mechanical strain to a three-dimensional cell-seeded hydrogel 2010, Tissue Engineering Part C, Methods.
289. Sullivan K.E., Black L.D. The role of cardiac fibroblasts in extracellular matrix-mediated signaling during normal and pathological cardiac development. J. Biomech. Eng. 2013, 135:071001.
290. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
291. Hirt M.N., Soerensen N.A., Bartholdt L.M., Boeddinghaus J., Schaaf S., Eder A., et al. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res. Cardiol. 2012, 107.
292. Boudou T., Legant W.R., Mu A., Borochin M.A., Thavandiran N., Radisic M., et al. A Microfabricated Platform to Measure and Manipulate the Mechanics of Engineered Cardiac Microtissues. Tissue Eng. A 2012, 18:910-919.
293. Liu M.Y., Montazeri S., Jedlovsky T., van Wert R., Zhang J., Li R.K., et al. Bio-stretch, a computerized cell strain apparatus for three dimensional organotypic cultures. In Vitro Cell. Dev. Biol. Anim. 1999, 35:87-93.
294. Akhyari P., Fedak P.W.M., Weisel R.D., Lee T.Y.J., Verma S., Mickle D.A.G., et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002, 106:I137-I142.
295. Shachar M., Benishti N., Cohen S. Effects of mechanical stimulation induced by compression and medium perfusion on cardiac tissue engineering. Biotechnol. Prog. 2012, 28:1551-1559.
296. Radisic M., Euloth M., Yang L.M., Langer R., Freed L.E., Vunjak-Novakovic G. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol. Bioeng. 2003, 82:403-414.
297. Radisic M., Yang L.M., Boublik J., Cohen R.J., Langer R., Freed L.E., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H507-H516.
298. Radisic M., Marsano A., Maidhof R., Wang Y., Vunjak-Novakovic G. Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protoc. 2008, 3:719-738.
299. Brown M.A., Iver R.K., Radisic M. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol. Prog. 2008, 24:907-920.
300. Sapir Y., Polyak B., Cohen S. Cardiac tissue engineering in magnetically actuated scaffolds. Nanotechnology 2014, 25.
301. Schaub M.C., Hefti M.A., Harder B.A., Eppenberger H.M. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J. Mol. Med. 1997, 75:901-920.
302. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., et al. Akt1 is required for physiological cardiac growth. Circulation 2006, 113:2097-2104.
303. Gwak S.-J., Bhang S.H., Kim I.-K., Kim S.-S., Cho S.-W., Jeon O., et al. The effect of cyclic strain on embryonic stem cell-derived cardiomyocytes. Biomaterials 2008, 29:844-856.
304. Shimko V.F., Claycomb W.C. Effect of mechanical loading on three-dimensional cultures of embryonic stem cell-derived cardiomyocytes. Tissue Eng. A 2008, 14:49-58.
305. Wan C.-r., Chung S., Kamm R.D. Differentiation of embryonic stem cells into cardiomyocytes in a compliant microfluidic system. Ann. Biomed. Eng. 2011, 39:1840-1847.
306. Bhang S.H., Gwak S.J., Lee T.J., Kim S.S., Park H.H., Park M.H., et al. Cyclic mechanical strain promotes transforming-growth-factor-beta1-mediated cardiomyogenic marker expression in bone-marrow-derived mesenchymal stem cells in vitro. Biotechnol. Appl. Biochem. 2010, 191-197. (England).
307. Ge D., Liu X., Li L., Wu J., Tu Q., Shi Y., et al. Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochem. Biophys. Res. Commun. 2009, 381:317-321.
308. Huang Y., Zheng L., Gong X., Jia X., Song W., Liu M., et al. Effect of Cyclic Strain on Cardiomyogenic Differentiation of Rat Bone Marrow Derived Mesenchymal Stem Cells. PLoS One 2012, 7:e34960.
309. Mihic A., Li J., Miyagi Y., Gagliardi M., Li S.H., Zu J., et al. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 2014, 35:2798-2808.
310. Cambier L., Plate M., Sucov H.M., Pashmforoush M. Nkx2-5 regulates cardiac growth through modulation of Wnt signaling by R-spondin3. Development 2014, 141:2959-2971.
311. George V., Colombo S., Targoff K.L. An early requirement for nkx2.5 ensures the first and second heart field ventricular identity and cardiac function into adulthood. Dev. Biol. 2015, 400:10-22.
312. Cysarz D., Lange S., Matthiessen P.F., Leeuwen P. Regular heartbeat dynamics are associated with cardiac health. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R368-R372.
313. Morgan K.Y., Black L.D. Investigation into the effects of varying frequency of mechanical stimulation in a cycle-by-cycle manner on engineered cardiac construct function. J. Tissue Eng. Regen. Med. 2015.
314. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18129-18134.
315. Tandon N., Cannizzaro C., Chao P.-H.G., Maidhof R., Marsano A., Au H.T.H., et al. Electrical stimulation systems for cardiac tissue engineering. Nat. Protoc. 2009, 4:155-173.
316. Tandon N., Marsano A., Maidhof R., Wan L., Park H., Vunjak-Novakovic G. Optimization of electrical stimulation parameters for cardiac tissue engineering. J. Tissue Eng. Regen. Med. 2011, 5:E115-E125.
317. Brevet A., Pinto E., Peacock J., Stockdale F.E. Myosin synthesis increased by electrical stimulation of skeletal muscle cell cultures. Science 1976, 193:1152-1154.
318. McDonough P.M., Glembotski C.C. Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction. J. Biol. Chem. 1992, 267:11665-11668.
319. Xia Y., McMillin J.B., Lewis A., Moore M., Zhu W.G., Williams R.S., et al. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J. Biol. Chem. 2000, 275:1855-1863.
320. Xia Y., Buja L.M., McMillin J.B. Activation of the cytochrome c gene by electrical stimulation in neonatal rat cardiac myocytes. Role of NRF-1 and c-Jun. J. Biol. Chem. 1998, 273:12593-12598.
321. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 2000, 105:1395-1406.
322. McKinsey T.A., Olson E.N. Cardiac hypertrophy: sorting out the circuitry. Curr. Opin. Genet. Dev. 1999, 9:267-274.
323. Baumgartner S., Halbach M., Krausgrill B., Maass M., Srinivasan S.P., Sahito R.G.A., et al. Electrophysiological and morphological maturation of murine fetal cardiomyocytes during electrical stimulation in vitro. J. Cardiovasc. Pharmacol. Ther. 2015, 20:104-112.
324. London B., Trudeau M.C., Newton K.P., Beyer A.K., Copeland N.G., Gilbert D.J., et al. Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ. Res. 1997, 81:870-878.
325. Volberg W.A., Koci B.J., Su W., Lin J., Zhou J. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J. Pharmacol. Exp. Ther. 2002, 302:320-327.
326. Moss A.J., Zareba W., Kaufman E.S., Gartman E., Peterson D.R., Benhorin J., et al. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002, 105:794-799.
327. Zhang X., Wang Q., Gablaski B., Lucchesi P., Zhao Y. A microdevice for studying intercellular electromechanical transduction in adult cardiac myocytes. Lab Chip 2013, 13:3090-3097.
328. Malchesky P.S. Artificial organs 2014: a year in review. Artif. Organs 2015, 39:260-287.
329. Au H.T.H., Cui B., Chu Z.E., Veres T., Radisic M. Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip 2009, 9:564-575.
330. Agarwal A., Goss J.A., Cho A., McCain M.L., Parker K.K. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab on a Chip 2013, 13:3599-3608.
331. Mathur A., Loskill P., Shao K., Huebsch N., Hong S., Marcus S.G., et al. Human iPSC-based cardiac microphysiological system for drug screening applications. Sci. Rep. 2015, 5:8883.
332. Ingber DE, Parker KK, Hamilton GA, Bahinski A. ORGAN CHIPS AND USES THEREOF. US Patent 20,140,342,445; 2014.
333. Hansen A., Eder A., Bönstrup M., Flato M., Mewe M., Schaaf S., et al. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 2010, 107:35-44.
334. Wang G., McCain M.L., Yang L., He A., Pasqualini F.S., Agarwal A., et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 2014, 20:616-623.
335. Chan C.Y., Huang P.-H., Guo F., Ding X., Kapur V., Mai J.D., et al. Accelerating drug discovery via organs-on-chips. Lab Chip 2013, 13:4697-4710.
336. Bhatia S.N., Ingber D.E. Microfluidic organs-on-chips. Nat. Biotechnol. 2014, 32:760-772.
337. Esch M.B., Smith A.S.T., Prot J.-M., Oleaga C., Hickman J.J., Shuler M.L. How multi-organ microdevices can help foster drug development. Adv. Drug Deliv. Rev. 2014, 69:158-169.
338. Farouz Y., Chen Y., Terzic A., Menasché P. Concise review: growing hearts in the right place: on the design of biomimetic materials for cardiac stem cell differentiation. Stem Cells 2015, 33:1021-1035.
339. Barash Y., Dvir T., Tandeitnik P., Ruvinov E., Guterman H., Cohen S. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. Tissue Eng. Part C Methods 2010, 16:1417-1426.
340. Chiu L.L.Y., Iyer R.K., Reis L.A., Nunes S.S., Radisic M. Cardiac tissue engineering: current state and perspectives. Front. Biosci. Landmark 2012, 17:1533-1550.
341. Maidhof R., Tandon N., Lee E.J., Luo J., Duan Y., Yeager K., et al. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 2012, 6:e12-e23.
342. Wang B., Wang G., To F., Butler J.R., Claude A., McLaughlin R.M., et al. Myocardial scaffold-based cardiac tissue engineering: application of coordinated mechanical and electrical stimulations. Langmuir 2013, 29:11109-11117.
343. Park H., Larson B.L., Kolewe M.E., Vunjak-Novakovic G., Freed L.E. Biomimetic scaffold combined with electrical stimulation and growth factor promotes tissue engineered cardiac development. Exp. Cell Res. 2014, 321:297-306.
344. Pietronave S., Zamperone A., Oltolina F., Colangelo D., Follenzi A., Novelli E., et al. Monophasic and biphasic electrical stimulation induces a precardiac differentiation in progenitor cells isolated from human heart. Stem Cells Dev. 2014, 23:888-898.
345. Martins A.M., Eng G., Caridade S.G., Mano J.F., Reis R.L., Vunjak-Novakovic G. Electrically conductive chitosan/carbon scaffolds for cardiac tissue engineering. Biomacromolecules 2014, 15:635-643.
346. Zhou J., Chen J., Sun H., Qiu X., Mou Y., Liu Z., et al. Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci. Rep. 2014, 4:3733.
347. Shin S.R., Jung S.M., Zalabany M., Kim K., Zorlutuna P., Kim Sb., et al. Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano 2013, 7:2369-2380.
348. Dvir T., Timko B.P., Brigham M.D., Naik S.R., Karajanagi S.S., Levy O., et al. Nanowired three-dimensional cardiac patches. Nat. Nanotechnol. 2011, 6:720-725.
349. You J.-O., Rafat M., Ye G.J.C., Auguste D.T. Nanoengineering the heart: conductive scaffolds enhance connexin 43 expression. Nano Lett. 2011, 11:3643-3648.
350. Berger H.J., Prasad S.K., Davidoff A.J., Pimental D., Ellingsen O., Marsh J.D., et al. Continual electric-field stimulation preserves contractile function of adult ventricular myocytes in primary culture. Am. J. Physiol. 1994, 266:H341-H349.
351. Burt J.M., Massey K.D., Minnich B.N. Uncoupling of cardiac-cells by fatty-acids - structure-activity-relationships. Am. J. Physiol. 1991, 260:C439-C448.
352. Zhao M., Bai H., Wang E., Forrester J.V., McCaig C.D. Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signaling through VEGF receptors. J. Cell Sci. 2004, 117:397-405.
353. Radisic M., Park H., Gerecht S., Cannizzaro C., Langer R., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc., B 2007, 362:1357-1368.
354. Shimizu T., Yamato M., Akutsu T., Shibata T., Isoi Y., Kikuchi A., et al. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J. Biomed. Mater. Res. 2002, 60:110-117.
355. Mehrhof F.B., Müller F.-U., Bergmann M.W., Li P., Wang Y., Schmitz W., et al. In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation 2001, 104:2088-2094.
356. Huynh K., McMullen J.R., Julius T.L., Tan J.W., Love J.E., Cemerlang N., et al. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes 2010, 59:1512-1520.
357. Kajstura J., Fiordaliso F., Andreoli A.M., Li B.S., Chimenti S., Medow M.S., et al. IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 2001, 50:1414-1424.
358. Chen M.Q., Xie X., Hollis Whittington R., Kovacs G.T.A., Wu J.C., Giovangrandi L. Cardiac differentiation of embryonic stem cells with point-source electrical stimulation. Engineering in Medicine and Biology Society, 2008 EMBS 2008 30th Annual International Conference of the IEEE2008 2008, 1729-1732.
359. Serena E., Figallo E., Tandon N., Cannizzaro C., Gerecht S., Elvassore N., et al. Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp. Cell Res. 2009, 315:3611-3619.
360. Chan Y.-C., Ting S., Lee Y.-K., Ng K.-M., Zhang J., Chen Z., et al. Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J. Cardiovasc. Transl. Res. 2013, 6:989-999.
361. Pavesi A., Soncini M., Zamperone A., Pietronave S., Medico E., Redaelli A., et al. Electrical conditioning of adipose-derived stem cells in a multi-chamber culture platform. Biotechnol. Bioeng. 2014, 111:1452-1463.
362. Hirt M.N., Boeddinghaus J., Mitchell A., Schaaf S., Boernchen C., Mueller C., et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J. Mol. Cell. Cardiol. 2014, 74:151-161.
363. Sauer H., Wartenberg M. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid. Redox Signal. 2005, 7:1423-1434.
364. Gassmann M., Fandrey J., Bichet S., Wartenberg M., Marti H.H., Bauer C., et al. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:2867-2872.
365. Sauer H., Rahimi G., Hescheler J., Wartenberg M. Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells. J. Cell. Biochem. 1999, 75:710-723.
366. Vunjak-Novakovic G., Tandon N., Godier A., Maidhof R., Marsano A., Martens T.P., et al. Challenges in cardiac tissue engineering. Tissue Eng. B Rev. 2010, 169-187.
367. Hahn C., Schwartz M.A. The role of cellular adaptation to mechanical forces in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2101-2107.
368. Hoffman B.D., Grashoff C., Schwartz M.A. Dynamic molecular processes mediate cellular mechanotransduction. Nature 2011, 475:316-323.
369. Young S.R., Gerard-O'Riley R., Kim J.B., Pavalko F.M. Focal adhesion kinase is important for fluid shear stress-induced mechanotransduction in osteoblasts. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2009, 24:411-424.
370. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008, 14:213-221.
371. Momtahan N., Sukavaneshvar S., Roeder B.L., Cook A.D. Strategies and processes to decellularize and recellularize hearts to generate functional organs and reduce the risk of thrombosis. Tissue Eng. Part B Rev. 2015, 21:115-132.
372. Hulsmann J., Aubin H., Kranz A., Godehardt E., Munakata H., Kamiya H., et al. A novel customizable modular bioreactor system for whole-heart cultivation under controlled 3D biomechanical stimulation. J. Artif. Organs 2013, 16:294-304.
373. Johnson P., Maxwell D.J., Tynan M.J., Allan L.D. Intracardiac pressures in the human fetus. Heart 2000, 84:59-63.
374. Feng Z.G., Matsumoto T., Nomura Y., Nakamura T. An electro-tensile bioreactor for 3-D culturing of cardiomyocytes - a bioreactor system that simulates the myocordium's electrical and mechanical response in vivo. IEEE Eng. Med. Biol. Mag. 2005, 24:73-79.
375. Isenberg B.C., Tranquillo R.T. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 2003, 31:937-949.
376. Miklas J.W., Nunes S.S., Sofla A., Reis L.A., Pahnke A., Xiao Y., et al. Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. Biofabrication 2014, 6:024113.
377. Lu L., Mende M., Yang X., Koerber H.-F., Schnittler H.-J., Weinert S., et al. Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Eng. A 2013, 19:403-414.
378. Corona B.T., Ward C.L., Baker H.B., Walters T.J., Christ G.J. Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. Tissue Eng. A 2014, 20:705-715.
379. Centers for Disease Control and Prevention National diabetes statistics report: estimates of diabetes and its burden in the United States 2014, US Department of Health and Human Services, Atlanta, GA. Services UDoHaH (Ed.).
380. Musialik-Lydka A., Sredniawa B., Pasyk S. Heart rate variability in heart failure. Kardiol. Pol. 2003, 58:10-16.
381. Arold S.P., Bartolák-Suki E., Suki B. Variable stretch pattern enhances surfactant secretion in alveolar type II cells in culture. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L574-L581.
382. Smyth J.W., Vogan J.M., Buch P.J., Zhang S.S., Fong T.S., Hong T.T., et al. Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane. Circ. Res. 2012, 110:978-989.
383. Morgan K.Y., Black L.D. Creation of a bioreactor for the application of variable amplitude mechanical stimulation of fibrin gel-based engineered cardiac tissue. Methods Mol. Biol. 2014, 1181:177-187.